Literature DB >> 20397005

Feasibility of aerosolized colistin in the era of escalating drug-resistant Pseudomonas pneumonia: pressing need for validation clinical trials.

Amar Safdar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20397005     DOI： 10.1007/s00134-010-1883-8

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  12 in total

1.  Lung deposition and efficiency of nebulized amikacin during Escherichia coli pneumonia in ventilated piglets.

Authors:  Ivan Goldstein; Frederic Wallet; Armelle Nicolas-Robin; Fabio Ferrari; Charles-Hugo Marquette; Jean-Jacques Rouby
Journal:  Am J Respir Crit Care Med       Date:  2002-10-11       Impact factor: 21.405

2.  Defining, treating and preventing hospital acquired pneumonia: European perspective.

Authors:  Antoni Torres; Santiago Ewig; Harmut Lode; Jean Carlet
Journal:  Intensive Care Med       Date:  2008-11-07       Impact factor: 17.440

3.  Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients.

Authors:  Matthew E Falagas; Petros I Rafailidis; Elda Ioannidou; Vangelis G Alexiou; Dimitrios K Matthaiou; Drosos E Karageorgopoulos; Anastasios Kapaskelis; Dimitra Nikita; Argyris Michalopoulos
Journal:  Int J Antimicrob Agents       Date:  2009-12-16       Impact factor: 5.283

4.  Use of aerosolized colistin sodium in cystic fibrosis patients awaiting lung transplantation.

Authors:  G S Bauldoff; D R Nunley; J D Manzetti; J H Dauber; R J Keenan
Journal:  Transplantation       Date:  1997-09-15       Impact factor: 4.939

5.  Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa.

Authors:  Qin Lu; Cassio Girardi; Mao Zhang; Belaïd Bouhemad; Kamel Louchahi; Olivier Petitjean; Frédéric Wallet; Marie-Helene Becquemin; Gilles Le Naour; Charles-Hugo Marquette; Jean-Jacques Rouby
Journal:  Intensive Care Med       Date:  2010-04-16       Impact factor: 17.440

6.  Neurotoxic and nephrotoxic effects of colistin in patients with renal disease.

Authors:  E Wolinsky; J D Hines
Journal:  N Engl J Med       Date:  1962-04-12       Impact factor: 91.245

Review 7.  Inhaled therapeutics for prevention and treatment of pneumonia.

Authors:  Amar Safdar; Samuel A Shelburne; Scott E Evans; Burton F Dickey
Journal:  Expert Opin Drug Saf       Date:  2009-07       Impact factor: 4.250

Review 8.  Aerosolized antibiotics for non-cystic fibrosis bronchiectasis.

Authors:  Bruce K Rubin
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2008-03       Impact factor: 2.849

9.  Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance.

Authors:  D E Ghannam; G H Rodriguez; I I Raad; A Safdar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-08-28       Impact factor: 3.267

10.  Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: a meta-analysis of comparative trials.

Authors:  Matthew E Falagas; Ilias I Siempos; Ioannis A Bliziotis; Argyris Michalopoulos
Journal:  Crit Care       Date:  2006       Impact factor: 9.097
View more
  1 in total

1.  Aerosolized amikacin in patients with difficult-to-treat pulmonary nontuberculous mycobacteriosis.

Authors:  A Safdar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-25       Impact factor: 3.267
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.